Kimberly Ha/LinkedIn
Apr 3, 2026, 17:33
Kimberly Ha: Epia Neuro Aims to Restore Movement in Stroke Survivors
Kimberly Ha, Founder and CEO at KKH Advisors, shared a post on LinkedIn:
”Epia Neuro is the latest medtech startup looking to tap the potential of brain-computer interface (BCI) technology, launching with a device that aims to turn brain signals into digital commands.
The San Francisco-based company is focusing its neural interface platform initially on stroke survivors.
The platform combines a minimally invasive, long-lifetime read/write brain-computer interface (pictured above) with assistive devices and AI-driven support, aiming to help stroke survivors translate neural signals into functional movement, according to an April 2 release.”
Stay updated with Hemostasis Today.
-
Oct 3, 2026, 05:52Kemal Karaagac: When Vitamin K Antagonists Remain Essential in Cardiac Care
-
Oct 3, 2026, 05:32Shiavax J. Rao: PERT 2026 Session Explores Long-Term Anticoagulation and DOAC Management
-
Oct 3, 2026, 05:13Parveen Yograj: Iron Deficiency and Anaemia – Diagnosis, Causes, and Treatment Guidelines
-
Oct 3, 2026, 00:25Antiplatelets May Be a Strong Option After Ischemic Stroke in Active Cancer – International Journal of Stroke
-
Oct 3, 2026, 00:24Mavis Agnes Kisakye: Honored to Join UNHLS Leadership in Advancing HIV Diagnostics in Uganda
-
Oct 3, 2026, 00:23Phil Spinella: Blood is for Bleeding, Salt Water is for Cooking pasta, Keeping it simple
-
Oct 3, 2026, 00:21Pablo Corral: The ANGPTL Axis in Dyslipidemia and Cardiovascular Risk
-
Oct 3, 2026, 00:20Raghavendra Rao: The Link Between Chronic Venous Disease and VTE May Be Less Robust Than Previously Thought
-
Oct 3, 2026, 00:19Nicolas Hubacz: Immune Cells in the Embryo